What is NDC 13668-587?

13668-587 is the product NDC for Erythromycin, Erythromycin 333 mg/1 tablet, delayed release, listed with the FDA by Torrent Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Erythromycin?

69 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Erythromycin NDC 13668-587 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-587Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0587Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13668-587-01	13668058701	100 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-587-01)Marketed from Oct 21, 2024
13668-587-05	13668058705	500 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-587-05)Marketed from Oct 21, 2024
13668-587-30	13668058730	30 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-587-30)Marketed from Oct 21, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 333 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Torrent Pharmaceuticals LimitedNDC labeler code 13668
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211975
Marketing start: Oct 21, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 13668-587_8c400049-2b9b-476d-a993-06aa5d3beba9SPL ID 8c400049-2b9b-476d-a993-06aa5d3beba9SPL set ID 66b0d891-8756-43d1-b046-6dba787dd96fRxCUI 310155, 310157, 315090UNII 63937KV33DUPC 0313668586015, 0313668587012
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668058701 followed by a unit qualifier and the quantity

Package 13668-0587-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 17, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin delayed-release tablets and other antibacterial drugs, erythromycin delayed-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin delayed-release tablets are indicated in the treatment of infections caused by susce…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 13668-587

What is NDC 13668-587?: 13668-587 is the product NDC for Erythromycin, Erythromycin 333 mg/1 tablet, delayed release, listed with the FDA by Torrent Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Erythromycin.
What is the active ingredient?: Erythromycin.
Who is the labeler?: Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erythromycin?: 69 other product NDCs are listed under this name. See all Erythromycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Erythromycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Sentiss Pharmaceuticals LLC	70244-031	70244-0031-0170244-0031-02
erythromycin	Erythromycin 250 mg/1	Capsule, Delayed release pelletsOral	Dr. Reddy's Labratories Inc.	75907-076	75907-0076-01
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3992	68071-3992-02
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ARMAS PHARMACEUTICALS INC.	72485-670	72485-0670-3172485-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ST. MARY'S MEDICAL PARK PHARMACY	60760-670	60760-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Redpharm Drug	67296-2128	67296-2128-03
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Fera Pharmaceuticals, LLC	48102-057	48102-0057-11
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-397	46708-0397-3046708-0397-3146708-0397-91
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-398	46708-0398-3046708-0398-3146708-0398-91
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-397	62332-0397-3062332-0397-3162332-0397-91

All 70 Erythromycin NDCs

Other NDCs under ANDA 211975

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211975
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 500 mg/1	Tablet, Delayed releaseOral	Torrent Pharmaceuticals Limited	13668-588
Erythromycin	Erythromycin 250 mg/1	Tablet, Delayed releaseOral	Torrent Pharmaceuticals Limited	13668-586
Erythromycin	Erythromycin 250 mg/1	Tablet, Delayed releaseOral	Golden State Medical Supply, Inc.	51407-853
Erythromycin	Erythromycin 500 mg/1	Tablet, Delayed releaseOral	Golden State Medical Supply, Inc.	51407-854